Yayın:
Stereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurna, Menekşe
dc.contributor.authorRzazade, Rashad
dc.contributor.authorCanoğlu, Mehmet Doğu
dc.contributor.authorÇağlar, Hale Başak
dc.contributor.authorMustafa Halil Akbörü
dc.contributor.authorRashad Rzazade
dc.contributor.authorMehmet Doğu Canoğlu
dc.contributor.authorHale Başak Çağlar
dc.contributor.orcid0000-0001-7464-7307
dc.contributor.orcid0000-0001-6661-4185
dc.contributor.orcid0000-0002-2283-6226
dc.contributor.orcid0009-0005-7215-541X
dc.contributor.orcid0000-0003-0412-4273
dc.contributor.orcid0009-0001-4800-0064
dc.date.accessioned2025-11-13T16:37:04Z
dc.date.issued2025-06-08
dc.identifier.doihttps://doi.org/10.1007/s12282-025-01731-5
dc.identifier.endpage1043
dc.identifier.issn1340-6868
dc.identifier.issue5
dc.identifier.openalexW4411124474
dc.identifier.startpage1035
dc.identifier.urihttps://hdl.handle.net/11421/10220
dc.identifier.urihttps://doi.org/10.1007/s12282-025-01731-5
dc.identifier.volume32
dc.language.isoen
dc.relation.ispartofBreast Cancer
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectRadiosurgery
dc.subjectSurgical oncology
dc.subjectBreast cancer
dc.subjectOncology
dc.subjectInternal medicine
dc.subjectBrain metastasis
dc.subjectTrastuzumab
dc.subjectCancer
dc.subjectRadiation therapy
dc.subjectMetastasis
dc.subject.sdg3
dc.titleStereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5075123195
local.authorid.openalexA5000091632
local.authorid.openalexA5014485286
local.authorid.openalexA5042455431

Dosyalar

Koleksiyonlar

Publications